
The average Bio-Techne Investor Relations in Minneapolis earns an estimated $82,056 annually. Bio-Techne's Investor Relations compensation is $125 more than the US average for a Investor Relations.
Last updated 7 months ago.
The majority of Investor Relations at Bio-Techne believe they're not compensated fairly. 50% of Investor Relations at Bio-Techne say they receive annual bonuses, and the majority (50%) are satisfied with their benefits. See more compensation ratings at Bio-Techne